These findings seem to support the existence of two discrete pathways of prostate carcinogenesis: ERG positive cancer that progresses from pattern 3 towards pattern 5, and ERG negative cancer that more often arises as a “de novo” high grade tumor. The gene discussed is ERG; the disease is prostatitis.